CN Stock MarketDetailed Quotes

Walvax Biotechnology (300142)

Watchlist
  • 13.82
  • +0.08+0.58%
Trading May 22 09:30 CST
22.10BMarket Cap77.21P/E (TTM)

Walvax Biotechnology (300142) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Autonomous vaccine2.15B89.00%
Intermediate product250.49M10.36%
Technical services9.88M0.41%
Other business5.72M0.24%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological medicine2.42B100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region679.27M28.09%
Overseas region522.04M21.59%
South China region400.71M16.57%
Southwest Northwest region346.88M14.34%
Central China region256.31M10.60%
Northeast North China region213.01M8.81%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More